ALS News Today Named 2026 Presenting Sponsor of ALS Network’s ASK ME Webinar Series

LOS ANGELES – March 9, 2026 – ALS News Today will serve as the presenting sponsor of the ALS Network’s ASK ME educational webinar series throughout 2026, supporting a year of expert-led programs designed to inform and empower people living with amyotrophic lateral sclerosis (ALS), their loved ones, and caregivers.

“The ASK ME series reflects what the ALS community is seeking — clear information, trusted guidance, and meaningful connection,” said Sheri Strahl, MPH, MBA, president and CEO of the ALS Network. “We’re pleased to partner with ALS News Today to reach more people affected by ALS and ensure they have access to timely education and resources.”

Through the partnership, ALS News Today will help expand awareness of the series across its digital platforms, connecting readers to trusted educational resources on research, care, policy, and everyday living with ALS.

“At Bionews, we recognize that advocacy organizations are essential drivers of progress for people navigating rare and chronic diseases,” said Anne FitzSimons, Director of Advocacy Partnerships, Bionews. “We’re honored to collaborate with the ALS Network on the ASK ME webinar series, helping deliver credible, expert perspectives on research, policy, and care to the community.”

The first featured session under the 2026 sponsorship will take place March 16 at 6 p.m. ET / 3 p.m. PT, focusing on the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS) and the advocacy efforts shaping the future of treatment access.

Hosted by the ALS Network and emceed by Jerry Dawson, president and CEO of ALS United, the free webinar, “ASK ME: ACT for ALS,” will feature Allison Nadeau, MPH, MBA, the ALS Network’s Director of Public Policy and Advocacy; Jinsy A. Andrews, MD, MSc of the Network of Excellence for ALS (NEALS); and Andrea Pauls Backman, MBA, of ALS Strategy Consulting, LLC.

The one-hour program will provide an overview of the landmark law, its impact since being signed in 2021, and why reauthorization remains critical for advancing ALS research and improving access to potential therapies.

The ASK ME series offers concise, high-impact presentations on topics of immediate importance to the ALS community, with previous webinars reaching thousands of viewers through live broadcasts and on-demand viewing.

Registration for the March 16 webinar and information about upcoming sessions is available through the ALS Network at askme.alsnetwork.org

About the ALS Network
The ALS Network partners with the ALS community to drive the global discovery of prevention strategies, treatments, and cures for ALS; provide access to quality care and connection; and promote initiatives to improve health outcomes. The ALS Network serves people with ALS and their families throughout California, Hawaii, and far beyond. For more information about ALS and the ALS Network, visit alsnetwork.org or email info@alsnetwork.org. You can find the ALS Network on social media at @yourALSnetwork.

About Bionews
Bionews is a digital health media company serving rare and chronic disease communities. Since 2013, it has built more than 50 condition-specific news sites where, each month, over one million patients and caregivers engage with research updates, authentic stories, and meaningful connections. Guided by its “For Rare, By Rare” philosophy and powered by a team in which more than half live with or care for someone with a complex condition, Bionews provides information and perspective for patients, caregivers, healthcare professionals, and industry leaders seeking to better understand the rare disease experience. Through science-driven reporting, education initiatives, advocacy partnerships, and community insights, Bionews elevates patient voices and creates a more informed dialogue across the healthcare landscape.